Daptomycin Activity Tested Against Gram-positive Bacteria Isolated from Medical Centers Located in China (2006)

被引：0

作者：

Chen, M. ^{[1
]}

Wang, H. ^{[1
]}

Turnidge, J. ^{[2
]}

Jones, R. ^{[3
]}

Sader, H. ^{[3
]}

机构：

[1] Beijing Union Med Coll Hosp, Beijing, Peoples R China

[2] Womens & Childrens Hosp, Adelaide, SA, Australia

[3] JMI Labs, N Liberty, IA USA

来源：

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2008年 / 12卷

关键词：

D O I：

10.1016/j.ijid.2008.05.722

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：E268 / E268

页数：1

共 50 条

[1] Update on the In Vitro Activity of Daptomycin Tested against 17,193 Gram-positive Bacteria Isolated from European Medical Centers (2005-2007)
Sader, H. S.
Moet, G.
Jones, R. N.
JOURNAL OF CHEMOTHERAPY, 2009, 21 (05) : 500 - 506
[2] Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006)
Castanheira, Mariana
Jones, Ronald N.
Sader, Helio S.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 61 (02) : 235 - 239
[3] Daptomycin in vitro activity tested against gram-positive strains collected from European and Latin American medical Centers in 2003
Sader, HS
Fritsche, TR
Streit, JM
Jones, RN
JOURNAL OF CHEMOTHERAPY, 2005, 17 (05) : 477 - 483
[4] Update on daptomycin activity and spectrum when tested against Gram-positive strains collected in European medical centres (2006)
Sader, H.
Rhomberg, P.
Fritsche, T.
Jones, R.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S522 - S523
[5] Activity of daptomycin against Gram-positive bacterial isolates from Indian medical centres (2006-2007)
Mathai, Dilip
Biedenbach, Douglas J.
Jones, Ronald N.
Bell, Jan M.
Turnidge, John
Sader, Helio S.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (05) : 497 - 499
[6] Daptomycin Activity Tested Against Linezolid-Nonsusceptible Gram-Positive Clinical Isolates
Mendes, Rodrigo E.
Jones, Ronald N.
Deshpande, Lalitagauri M.
Ross, James E.
Sader, Helio S.
MICROBIAL DRUG RESISTANCE, 2009, 15 (04) : 245 - 249
[7] Daptomycin activity when tested against uncommonly isolated streptococcal species and three other Gram-positive species groups
Sader, H. S.
Flamm, R. K.
Jones, R. N.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S62 - S62
[8] Dalbavancin Comparative Activity Tested Against Gram-positive Species in German Medical Centers: Results from the DECIDE Program
Just-Nuebling, G.
Falk, W.
Schmitz, F. J.
Rodloff, A.
Biedenbach, D.
Jones, R.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E259 - E260
[9] Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008)
Sader, Helio S.
Jones, Ronald N.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2009, 65 (02) : 158 - 162
[10] Dalbavancin activity tested against rarely isolated Gram-positive organism species from Europe
Jones, R.
Sader, H.
Fritsche, T.
Stilwell, M.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S195 - S196

← 1 2 3 4 5 →